Ann: Change of Director's Interest Notice, page-31

Every reason both BM and RC would be trying to distance themselves from one of the worst performing stocks on the ASX for a start the fact they were on the board when the disastrous Teva acquisition was done so called pipeline of products still being written off . The share market in general has has experienced very strong growth over the past 5 years and MYX LT share holders capital decimated . MYX dropped from the ASX 200 downgraded numerous times at one point .19 from a once high of more than $2 . Why wouldn't very successful business partners BM and RC want to distance themselves completely and put the whole sorry saga behind them , heavily involved with a company that is almost totally reliant on a product that Mithra developed and owns to hopefully enable company to report a net profit within the next couple of years provided Nextstellis actually proves what SR refers to as a game changer . Now Mithra has someone very well qualified / experienced in the US Pharma industry on Maynes board new investors entering this stock around where we've fallen to could stand a better than even chance of making money . Surprised not more interest probably will be after this ongoing selling/off loading ends .